Dysregulated release of insulin in response to changes in physiological glucose is central to the pathophysiology of type-1 (T1D) and type-2 (T2D) diabetes2–4, thus efforts to increase insulin secretion in response to physiological demands represents a significant area of interest. This evidence concerns the gene INS and type 1 diabetes mellitus.